nodes	percent_of_prediction	percent_of_DWPC	metapath
Mivacurium—BCHE—Perindopril—coronary artery disease	0.284	0.547	CbGbCtD
Mivacurium—BCHE—Ramipril—coronary artery disease	0.236	0.453	CbGbCtD
Mivacurium—CHRND—pericardium—coronary artery disease	0.027	0.5	CbGeAlD
Mivacurium—CHRND—heart—coronary artery disease	0.00417	0.0773	CbGeAlD
Mivacurium—CHRND—cardiovascular system—coronary artery disease	0.00393	0.0729	CbGeAlD
Mivacurium—CHRNA2—heart—coronary artery disease	0.00289	0.0535	CbGeAlD
Mivacurium—CHRNB1—heart—coronary artery disease	0.00269	0.0498	CbGeAlD
Mivacurium—CHRNA2—blood—coronary artery disease	0.00216	0.0399	CbGeAlD
Mivacurium—CHRNB1—blood—coronary artery disease	0.00201	0.0372	CbGeAlD
Mivacurium—BCHE—cardiac ventricle—coronary artery disease	0.00174	0.0323	CbGeAlD
Mivacurium—CHRM2—heart—coronary artery disease	0.00172	0.0319	CbGeAlD
Mivacurium—CHRM2—cardiovascular system—coronary artery disease	0.00163	0.0301	CbGeAlD
Mivacurium—Cardiac disorder—Valsartan—coronary artery disease	0.00115	0.00399	CcSEcCtD
Mivacurium—BCHE—heart—coronary artery disease	0.00115	0.0212	CbGeAlD
Mivacurium—Anaphylactic shock—Acetylsalicylic acid—coronary artery disease	0.00114	0.00397	CcSEcCtD
Mivacurium—Erythema—Simvastatin—coronary artery disease	0.00114	0.00397	CcSEcCtD
Mivacurium—Muscle spasms—Eplerenone—coronary artery disease	0.00112	0.00391	CcSEcCtD
Mivacurium—Angiopathy—Valsartan—coronary artery disease	0.00112	0.0039	CcSEcCtD
Mivacurium—Immune system disorder—Valsartan—coronary artery disease	0.00112	0.00389	CcSEcCtD
Mivacurium—Angiopathy—Olmesartan—coronary artery disease	0.00112	0.00388	CcSEcCtD
Mivacurium—Flushing—Niacin—coronary artery disease	0.00112	0.00388	CcSEcCtD
Mivacurium—Mediastinal disorder—Valsartan—coronary artery disease	0.00111	0.00388	CcSEcCtD
Mivacurium—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.00111	0.00387	CcSEcCtD
Mivacurium—Mediastinal disorder—Olmesartan—coronary artery disease	0.00111	0.00386	CcSEcCtD
Mivacurium—Arrhythmia—Olmesartan—coronary artery disease	0.0011	0.00382	CcSEcCtD
Mivacurium—Cardiac disorder—Pravastatin—coronary artery disease	0.0011	0.00382	CcSEcCtD
Mivacurium—Flushing—Pravastatin—coronary artery disease	0.0011	0.00382	CcSEcCtD
Mivacurium—Muscle spasms—Simvastatin—coronary artery disease	0.0011	0.00381	CcSEcCtD
Mivacurium—Angiopathy—Niacin—coronary artery disease	0.00109	0.00379	CcSEcCtD
Mivacurium—Bradycardia—Perindopril—coronary artery disease	0.00109	0.00378	CcSEcCtD
Mivacurium—BCHE—cardiovascular system—coronary artery disease	0.00108	0.02	CbGeAlD
Mivacurium—Arrhythmia—Niacin—coronary artery disease	0.00107	0.00374	CcSEcCtD
Mivacurium—Cardiac disorder—Trandolapril—coronary artery disease	0.00107	0.00371	CcSEcCtD
Mivacurium—Flushing—Trandolapril—coronary artery disease	0.00107	0.00371	CcSEcCtD
Mivacurium—Flushing—Enalapril—coronary artery disease	0.00106	0.0037	CcSEcCtD
Mivacurium—Urticaria—Gemfibrozil—coronary artery disease	0.00106	0.00369	CcSEcCtD
Mivacurium—Arrhythmia—Pravastatin—coronary artery disease	0.00106	0.00368	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Fenofibrate—coronary artery disease	0.00106	0.00367	CcSEcCtD
Mivacurium—Bronchospasm—Ramipril—coronary artery disease	0.00105	0.00367	CcSEcCtD
Mivacurium—Cardiac disorder—Telmisartan—coronary artery disease	0.00105	0.00365	CcSEcCtD
Mivacurium—Flushing—Telmisartan—coronary artery disease	0.00105	0.00365	CcSEcCtD
Mivacurium—Erythema—Niacin—coronary artery disease	0.00105	0.00364	CcSEcCtD
Mivacurium—Angiopathy—Trandolapril—coronary artery disease	0.00104	0.00363	CcSEcCtD
Mivacurium—Immune system disorder—Trandolapril—coronary artery disease	0.00104	0.00361	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Clopidogrel—coronary artery disease	0.00104	0.00361	CcSEcCtD
Mivacurium—Mediastinal disorder—Trandolapril—coronary artery disease	0.00104	0.0036	CcSEcCtD
Mivacurium—Muscle spasms—Valsartan—coronary artery disease	0.00104	0.0036	CcSEcCtD
Mivacurium—Dizziness—Penbutolol—coronary artery disease	0.00103	0.0036	CcSEcCtD
Mivacurium—Bronchospasm—Timolol—coronary artery disease	0.00103	0.00358	CcSEcCtD
Mivacurium—Muscle spasms—Olmesartan—coronary artery disease	0.00103	0.00358	CcSEcCtD
Mivacurium—Arrhythmia—Trandolapril—coronary artery disease	0.00103	0.00357	CcSEcCtD
Mivacurium—Angiopathy—Telmisartan—coronary artery disease	0.00102	0.00356	CcSEcCtD
Mivacurium—Arrhythmia—Enalapril—coronary artery disease	0.00102	0.00356	CcSEcCtD
Mivacurium—Immune system disorder—Telmisartan—coronary artery disease	0.00102	0.00355	CcSEcCtD
Mivacurium—Flushing—Captopril—coronary artery disease	0.00102	0.00355	CcSEcCtD
Mivacurium—Mediastinal disorder—Telmisartan—coronary artery disease	0.00102	0.00354	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—coronary artery disease	0.00101	0.00352	CcSEcCtD
Mivacurium—Arrhythmia—Telmisartan—coronary artery disease	0.00101	0.00351	CcSEcCtD
Mivacurium—Muscle spasms—Niacin—coronary artery disease	0.00101	0.0035	CcSEcCtD
Mivacurium—Anaphylactic shock—Clopidogrel—coronary artery disease	0.001	0.00348	CcSEcCtD
Mivacurium—Erythema—Enalapril—coronary artery disease	0.000997	0.00347	CcSEcCtD
Mivacurium—Anaphylactic shock—Lovastatin—coronary artery disease	0.000995	0.00346	CcSEcCtD
Mivacurium—Tachycardia—Fenofibrate—coronary artery disease	0.000994	0.00346	CcSEcCtD
Mivacurium—Muscle spasms—Pravastatin—coronary artery disease	0.000991	0.00345	CcSEcCtD
Mivacurium—Cardiac disorder—Perindopril—coronary artery disease	0.00099	0.00344	CcSEcCtD
Mivacurium—Flushing—Perindopril—coronary artery disease	0.00099	0.00344	CcSEcCtD
Mivacurium—Skin disorder—Fenofibrate—coronary artery disease	0.000989	0.00344	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—coronary artery disease	0.000989	0.00344	CcSEcCtD
Mivacurium—Erythema—Telmisartan—coronary artery disease	0.000983	0.00342	CcSEcCtD
Mivacurium—BCHE—cardiac atrium—coronary artery disease	0.000979	0.0181	CbGeAlD
Mivacurium—Anaphylactic shock—Ezetimibe—coronary artery disease	0.000976	0.00339	CcSEcCtD
Mivacurium—Skin disorder—Clopidogrel—coronary artery disease	0.000973	0.00338	CcSEcCtD
Mivacurium—Angiopathy—Perindopril—coronary artery disease	0.000967	0.00337	CcSEcCtD
Mivacurium—Muscle spasms—Trandolapril—coronary artery disease	0.000962	0.00335	CcSEcCtD
Mivacurium—Mediastinal disorder—Perindopril—coronary artery disease	0.000961	0.00334	CcSEcCtD
Mivacurium—Muscle spasms—Enalapril—coronary artery disease	0.000958	0.00333	CcSEcCtD
Mivacurium—Bronchospasm—Lisinopril—coronary artery disease	0.000956	0.00332	CcSEcCtD
Mivacurium—Arrhythmia—Perindopril—coronary artery disease	0.000953	0.00331	CcSEcCtD
Mivacurium—Hypotension—Fenofibrate—coronary artery disease	0.000952	0.00331	CcSEcCtD
Mivacurium—Skin disorder—Ezetimibe—coronary artery disease	0.000948	0.0033	CcSEcCtD
Mivacurium—Muscle spasms—Telmisartan—coronary artery disease	0.000945	0.00329	CcSEcCtD
Mivacurium—Angiopathy—Furosemide—coronary artery disease	0.00094	0.00327	CcSEcCtD
Mivacurium—Immune system disorder—Furosemide—coronary artery disease	0.000936	0.00326	CcSEcCtD
Mivacurium—Hypotension—Clopidogrel—coronary artery disease	0.000936	0.00325	CcSEcCtD
Mivacurium—Urticaria—Rosuvastatin—coronary artery disease	0.000932	0.00324	CcSEcCtD
Mivacurium—Anaphylactic shock—Simvastatin—coronary artery disease	0.00093	0.00324	CcSEcCtD
Mivacurium—Erythema—Perindopril—coronary artery disease	0.000928	0.00323	CcSEcCtD
Mivacurium—Flushing—Losartan—coronary artery disease	0.000928	0.00323	CcSEcCtD
Mivacurium—Skin disorder—Eplerenone—coronary artery disease	0.000927	0.00323	CcSEcCtD
Mivacurium—Arrhythmia—Furosemide—coronary artery disease	0.000926	0.00322	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.00091	0.00317	CcSEcCtD
Mivacurium—Angiopathy—Losartan—coronary artery disease	0.000907	0.00316	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000906	0.00315	CcSEcCtD
Mivacurium—Urticaria—Acetylsalicylic acid—coronary artery disease	0.000906	0.00315	CcSEcCtD
Mivacurium—Erythema—Furosemide—coronary artery disease	0.000902	0.00314	CcSEcCtD
Mivacurium—Arrhythmia—Losartan—coronary artery disease	0.000893	0.00311	CcSEcCtD
Mivacurium—Muscle spasms—Perindopril—coronary artery disease	0.000892	0.0031	CcSEcCtD
Mivacurium—Hypotension—Eplerenone—coronary artery disease	0.000892	0.0031	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.000885	0.00308	CcSEcCtD
Mivacurium—Dizziness—Gemfibrozil—coronary artery disease	0.000883	0.00307	CcSEcCtD
Mivacurium—Anaphylactic shock—Valsartan—coronary artery disease	0.000879	0.00306	CcSEcCtD
Mivacurium—Anaphylactic shock—Olmesartan—coronary artery disease	0.000874	0.00304	CcSEcCtD
Mivacurium—Erythema—Losartan—coronary artery disease	0.000871	0.00303	CcSEcCtD
Mivacurium—Muscle spasms—Furosemide—coronary artery disease	0.000868	0.00302	CcSEcCtD
Mivacurium—Dizziness—Ticagrelor—coronary artery disease	0.000862	0.003	CcSEcCtD
Mivacurium—BCHE—blood—coronary artery disease	0.000855	0.0158	CbGeAlD
Mivacurium—Anaphylactic shock—Niacin—coronary artery disease	0.000854	0.00297	CcSEcCtD
Mivacurium—Bradycardia—Timolol—coronary artery disease	0.000854	0.00297	CcSEcCtD
Mivacurium—Skin disorder—Valsartan—coronary artery disease	0.000853	0.00297	CcSEcCtD
Mivacurium—Tachycardia—Olmesartan—coronary artery disease	0.000853	0.00297	CcSEcCtD
Mivacurium—Skin disorder—Olmesartan—coronary artery disease	0.000849	0.00295	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.000846	0.00294	CcSEcCtD
Mivacurium—Rash—Gemfibrozil—coronary artery disease	0.000842	0.00293	CcSEcCtD
Mivacurium—Anaphylactic shock—Pravastatin—coronary artery disease	0.000841	0.00293	CcSEcCtD
Mivacurium—Dermatitis—Gemfibrozil—coronary artery disease	0.000841	0.00292	CcSEcCtD
Mivacurium—Muscle spasms—Losartan—coronary artery disease	0.000837	0.00291	CcSEcCtD
Mivacurium—Tachycardia—Niacin—coronary artery disease	0.000834	0.0029	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000831	0.00289	CcSEcCtD
Mivacurium—Skin disorder—Niacin—coronary artery disease	0.00083	0.00289	CcSEcCtD
Mivacurium—Rash—Ticagrelor—coronary artery disease	0.000822	0.00286	CcSEcCtD
Mivacurium—Dermatitis—Ticagrelor—coronary artery disease	0.000821	0.00286	CcSEcCtD
Mivacurium—Hypotension—Valsartan—coronary artery disease	0.000821	0.00286	CcSEcCtD
Mivacurium—Hypotension—Olmesartan—coronary artery disease	0.000817	0.00284	CcSEcCtD
Mivacurium—Anaphylactic shock—Enalapril—coronary artery disease	0.000814	0.00283	CcSEcCtD
Mivacurium—Urticaria—Fenofibrate—coronary artery disease	0.000809	0.00281	CcSEcCtD
Mivacurium—Anaphylactic shock—Telmisartan—coronary artery disease	0.000802	0.00279	CcSEcCtD
Mivacurium—Hypotension—Niacin—coronary artery disease	0.000798	0.00278	CcSEcCtD
Mivacurium—Tachycardia—Trandolapril—coronary artery disease	0.000797	0.00277	CcSEcCtD
Mivacurium—Flushing—Ramipril—coronary artery disease	0.000796	0.00277	CcSEcCtD
Mivacurium—Urticaria—Clopidogrel—coronary artery disease	0.000795	0.00277	CcSEcCtD
Mivacurium—Tachycardia—Enalapril—coronary artery disease	0.000794	0.00276	CcSEcCtD
Mivacurium—Skin disorder—Trandolapril—coronary artery disease	0.000793	0.00276	CcSEcCtD
Mivacurium—Bradycardia—Lisinopril—coronary artery disease	0.000792	0.00275	CcSEcCtD
Mivacurium—Urticaria—Lovastatin—coronary artery disease	0.00079	0.00275	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000785	0.00273	CcSEcCtD
Mivacurium—Tachycardia—Telmisartan—coronary artery disease	0.000783	0.00272	CcSEcCtD
Mivacurium—Anaphylactic shock—Captopril—coronary artery disease	0.00078	0.00271	CcSEcCtD
Mivacurium—Skin disorder—Telmisartan—coronary artery disease	0.000779	0.00271	CcSEcCtD
Mivacurium—Cardiac disorder—Timolol—coronary artery disease	0.000778	0.00271	CcSEcCtD
Mivacurium—Dizziness—Rosuvastatin—coronary artery disease	0.000776	0.0027	CcSEcCtD
Mivacurium—Urticaria—Ezetimibe—coronary artery disease	0.000775	0.0027	CcSEcCtD
Mivacurium—Immune system disorder—Ramipril—coronary artery disease	0.000775	0.00269	CcSEcCtD
Mivacurium—Mediastinal disorder—Ramipril—coronary artery disease	0.000773	0.00269	CcSEcCtD
Mivacurium—Arrhythmia—Ramipril—coronary artery disease	0.000766	0.00266	CcSEcCtD
Mivacurium—Hypotension—Trandolapril—coronary artery disease	0.000763	0.00265	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	0.000763	0.00265	CcSEcCtD
Mivacurium—Tachycardia—Captopril—coronary artery disease	0.000762	0.00265	CcSEcCtD
Mivacurium—Angiopathy—Timolol—coronary artery disease	0.000761	0.00265	CcSEcCtD
Mivacurium—Hypotension—Enalapril—coronary artery disease	0.00076	0.00264	CcSEcCtD
Mivacurium—Anaphylactic shock—Perindopril—coronary artery disease	0.000758	0.00264	CcSEcCtD
Mivacurium—Immune system disorder—Timolol—coronary artery disease	0.000757	0.00263	CcSEcCtD
Mivacurium—Mediastinal disorder—Timolol—coronary artery disease	0.000756	0.00263	CcSEcCtD
Mivacurium—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000754	0.00262	CcSEcCtD
Mivacurium—Hypotension—Telmisartan—coronary artery disease	0.00075	0.00261	CcSEcCtD
Mivacurium—Arrhythmia—Timolol—coronary artery disease	0.000749	0.00261	CcSEcCtD
Mivacurium—Erythema—Ramipril—coronary artery disease	0.000747	0.0026	CcSEcCtD
Mivacurium—Rash—Rosuvastatin—coronary artery disease	0.00074	0.00257	CcSEcCtD
Mivacurium—Tachycardia—Perindopril—coronary artery disease	0.000739	0.00257	CcSEcCtD
Mivacurium—Dermatitis—Rosuvastatin—coronary artery disease	0.000739	0.00257	CcSEcCtD
Mivacurium—Urticaria—Simvastatin—coronary artery disease	0.000739	0.00257	CcSEcCtD
Mivacurium—Anaphylactic shock—Furosemide—coronary artery disease	0.000736	0.00256	CcSEcCtD
Mivacurium—Skin disorder—Perindopril—coronary artery disease	0.000736	0.00256	CcSEcCtD
Mivacurium—Erythema—Timolol—coronary artery disease	0.00073	0.00254	CcSEcCtD
Mivacurium—Hypotension—Captopril—coronary artery disease	0.000729	0.00254	CcSEcCtD
Mivacurium—Flushing—Lisinopril—coronary artery disease	0.000722	0.00251	CcSEcCtD
Mivacurium—Rash—Acetylsalicylic acid—coronary artery disease	0.000719	0.0025	CcSEcCtD
Mivacurium—Dermatitis—Acetylsalicylic acid—coronary artery disease	0.000718	0.0025	CcSEcCtD
Mivacurium—Muscle spasms—Ramipril—coronary artery disease	0.000718	0.0025	CcSEcCtD
Mivacurium—Skin disorder—Furosemide—coronary artery disease	0.000715	0.00249	CcSEcCtD
Mivacurium—Anaphylactic shock—Losartan—coronary artery disease	0.000711	0.00247	CcSEcCtD
Mivacurium—Hypotension—Perindopril—coronary artery disease	0.000708	0.00246	CcSEcCtD
Mivacurium—Angiopathy—Lisinopril—coronary artery disease	0.000706	0.00245	CcSEcCtD
Mivacurium—Mediastinal disorder—Lisinopril—coronary artery disease	0.000701	0.00244	CcSEcCtD
Mivacurium—Urticaria—Valsartan—coronary artery disease	0.000698	0.00243	CcSEcCtD
Mivacurium—Arrhythmia—Lisinopril—coronary artery disease	0.000695	0.00242	CcSEcCtD
Mivacurium—Urticaria—Olmesartan—coronary artery disease	0.000695	0.00242	CcSEcCtD
Mivacurium—Tachycardia—Losartan—coronary artery disease	0.000694	0.00241	CcSEcCtD
Mivacurium—Hypotension—Furosemide—coronary artery disease	0.000688	0.00239	CcSEcCtD
Mivacurium—Urticaria—Niacin—coronary artery disease	0.000679	0.00236	CcSEcCtD
Mivacurium—Erythema—Lisinopril—coronary artery disease	0.000677	0.00236	CcSEcCtD
Mivacurium—Dizziness—Fenofibrate—coronary artery disease	0.000674	0.00234	CcSEcCtD
Mivacurium—Urticaria—Pravastatin—coronary artery disease	0.000668	0.00232	CcSEcCtD
Mivacurium—Hypotension—Losartan—coronary artery disease	0.000664	0.00231	CcSEcCtD
Mivacurium—Dizziness—Clopidogrel—coronary artery disease	0.000662	0.0023	CcSEcCtD
Mivacurium—Dizziness—Lovastatin—coronary artery disease	0.000658	0.00229	CcSEcCtD
Mivacurium—Muscle spasms—Lisinopril—coronary artery disease	0.000651	0.00226	CcSEcCtD
Mivacurium—Urticaria—Trandolapril—coronary artery disease	0.000649	0.00226	CcSEcCtD
Mivacurium—Urticaria—Enalapril—coronary artery disease	0.000646	0.00225	CcSEcCtD
Mivacurium—Dizziness—Ezetimibe—coronary artery disease	0.000645	0.00224	CcSEcCtD
Mivacurium—Rash—Fenofibrate—coronary artery disease	0.000642	0.00223	CcSEcCtD
Mivacurium—Dermatitis—Fenofibrate—coronary artery disease	0.000642	0.00223	CcSEcCtD
Mivacurium—Urticaria—Telmisartan—coronary artery disease	0.000637	0.00222	CcSEcCtD
Mivacurium—Dizziness—Eplerenone—coronary artery disease	0.000631	0.0022	CcSEcCtD
Mivacurium—Rash—Clopidogrel—coronary artery disease	0.000631	0.0022	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	0.000631	0.0022	CcSEcCtD
Mivacurium—Dermatitis—Clopidogrel—coronary artery disease	0.000631	0.00219	CcSEcCtD
Mivacurium—Rash—Lovastatin—coronary artery disease	0.000627	0.00218	CcSEcCtD
Mivacurium—Dermatitis—Lovastatin—coronary artery disease	0.000627	0.00218	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	0.000617	0.00215	CcSEcCtD
Mivacurium—Dizziness—Simvastatin—coronary artery disease	0.000615	0.00214	CcSEcCtD
Mivacurium—Rash—Ezetimibe—coronary artery disease	0.000615	0.00214	CcSEcCtD
Mivacurium—Dermatitis—Ezetimibe—coronary artery disease	0.000615	0.00214	CcSEcCtD
Mivacurium—Anaphylactic shock—Ramipril—coronary artery disease	0.000609	0.00212	CcSEcCtD
Mivacurium—Rash—Eplerenone—coronary artery disease	0.000602	0.00209	CcSEcCtD
Mivacurium—Urticaria—Perindopril—coronary artery disease	0.000602	0.00209	CcSEcCtD
Mivacurium—Dermatitis—Eplerenone—coronary artery disease	0.000602	0.00209	CcSEcCtD
Mivacurium—Anaphylactic shock—Timolol—coronary artery disease	0.000596	0.00207	CcSEcCtD
Mivacurium—Tachycardia—Ramipril—coronary artery disease	0.000595	0.00207	CcSEcCtD
Mivacurium—Skin disorder—Ramipril—coronary artery disease	0.000592	0.00206	CcSEcCtD
Mivacurium—Rash—Simvastatin—coronary artery disease	0.000587	0.00204	CcSEcCtD
Mivacurium—Dermatitis—Simvastatin—coronary artery disease	0.000586	0.00204	CcSEcCtD
Mivacurium—Urticaria—Furosemide—coronary artery disease	0.000585	0.00204	CcSEcCtD
Mivacurium—Dizziness—Valsartan—coronary artery disease	0.000581	0.00202	CcSEcCtD
Mivacurium—Skin disorder—Timolol—coronary artery disease	0.000579	0.00201	CcSEcCtD
Mivacurium—Dizziness—Olmesartan—coronary artery disease	0.000578	0.00201	CcSEcCtD
Mivacurium—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	0.000572	0.00199	CcSEcCtD
Mivacurium—Hypotension—Ramipril—coronary artery disease	0.000569	0.00198	CcSEcCtD
Mivacurium—Dizziness—Niacin—coronary artery disease	0.000565	0.00197	CcSEcCtD
Mivacurium—Urticaria—Losartan—coronary artery disease	0.000565	0.00196	CcSEcCtD
Mivacurium—Hypotension—Timolol—coronary artery disease	0.000557	0.00194	CcSEcCtD
Mivacurium—Dizziness—Pravastatin—coronary artery disease	0.000556	0.00193	CcSEcCtD
Mivacurium—Rash—Valsartan—coronary artery disease	0.000554	0.00193	CcSEcCtD
Mivacurium—Dermatitis—Valsartan—coronary artery disease	0.000553	0.00193	CcSEcCtD
Mivacurium—Anaphylactic shock—Lisinopril—coronary artery disease	0.000553	0.00192	CcSEcCtD
Mivacurium—Rash—Olmesartan—coronary artery disease	0.000551	0.00192	CcSEcCtD
Mivacurium—Dermatitis—Olmesartan—coronary artery disease	0.000551	0.00192	CcSEcCtD
Mivacurium—Dizziness—Trandolapril—coronary artery disease	0.00054	0.00188	CcSEcCtD
Mivacurium—Tachycardia—Lisinopril—coronary artery disease	0.000539	0.00188	CcSEcCtD
Mivacurium—Rash—Niacin—coronary artery disease	0.000539	0.00187	CcSEcCtD
Mivacurium—Dermatitis—Niacin—coronary artery disease	0.000538	0.00187	CcSEcCtD
Mivacurium—Dizziness—Enalapril—coronary artery disease	0.000538	0.00187	CcSEcCtD
Mivacurium—Skin disorder—Lisinopril—coronary artery disease	0.000537	0.00187	CcSEcCtD
Mivacurium—Dizziness—Telmisartan—coronary artery disease	0.000531	0.00185	CcSEcCtD
Mivacurium—Rash—Pravastatin—coronary artery disease	0.00053	0.00184	CcSEcCtD
Mivacurium—Dermatitis—Pravastatin—coronary artery disease	0.00053	0.00184	CcSEcCtD
Mivacurium—Hypotension—Lisinopril—coronary artery disease	0.000516	0.0018	CcSEcCtD
Mivacurium—Dizziness—Captopril—coronary artery disease	0.000516	0.00179	CcSEcCtD
Mivacurium—Rash—Trandolapril—coronary artery disease	0.000515	0.00179	CcSEcCtD
Mivacurium—Dermatitis—Trandolapril—coronary artery disease	0.000515	0.00179	CcSEcCtD
Mivacurium—Rash—Enalapril—coronary artery disease	0.000513	0.00178	CcSEcCtD
Mivacurium—Dermatitis—Enalapril—coronary artery disease	0.000512	0.00178	CcSEcCtD
Mivacurium—Rash—Telmisartan—coronary artery disease	0.000506	0.00176	CcSEcCtD
Mivacurium—Dermatitis—Telmisartan—coronary artery disease	0.000505	0.00176	CcSEcCtD
Mivacurium—Dizziness—Perindopril—coronary artery disease	0.000501	0.00174	CcSEcCtD
Mivacurium—Rash—Captopril—coronary artery disease	0.000492	0.00171	CcSEcCtD
Mivacurium—Dermatitis—Captopril—coronary artery disease	0.000492	0.00171	CcSEcCtD
Mivacurium—Dizziness—Furosemide—coronary artery disease	0.000487	0.00169	CcSEcCtD
Mivacurium—Urticaria—Ramipril—coronary artery disease	0.000484	0.00168	CcSEcCtD
Mivacurium—Rash—Perindopril—coronary artery disease	0.000478	0.00166	CcSEcCtD
Mivacurium—Dermatitis—Perindopril—coronary artery disease	0.000477	0.00166	CcSEcCtD
Mivacurium—Urticaria—Timolol—coronary artery disease	0.000473	0.00165	CcSEcCtD
Mivacurium—Dizziness—Losartan—coronary artery disease	0.00047	0.00163	CcSEcCtD
Mivacurium—Rash—Furosemide—coronary artery disease	0.000464	0.00162	CcSEcCtD
Mivacurium—Dermatitis—Furosemide—coronary artery disease	0.000464	0.00161	CcSEcCtD
Mivacurium—Rash—Losartan—coronary artery disease	0.000448	0.00156	CcSEcCtD
Mivacurium—Dermatitis—Losartan—coronary artery disease	0.000448	0.00156	CcSEcCtD
Mivacurium—Urticaria—Lisinopril—coronary artery disease	0.000439	0.00153	CcSEcCtD
Mivacurium—Dizziness—Ramipril—coronary artery disease	0.000403	0.0014	CcSEcCtD
Mivacurium—Dizziness—Timolol—coronary artery disease	0.000394	0.00137	CcSEcCtD
Mivacurium—Rash—Ramipril—coronary artery disease	0.000384	0.00134	CcSEcCtD
Mivacurium—Dermatitis—Ramipril—coronary artery disease	0.000384	0.00134	CcSEcCtD
Mivacurium—Rash—Timolol—coronary artery disease	0.000376	0.00131	CcSEcCtD
Mivacurium—Dermatitis—Timolol—coronary artery disease	0.000375	0.00131	CcSEcCtD
Mivacurium—Dizziness—Lisinopril—coronary artery disease	0.000365	0.00127	CcSEcCtD
Mivacurium—Rash—Lisinopril—coronary artery disease	0.000348	0.00121	CcSEcCtD
Mivacurium—Dermatitis—Lisinopril—coronary artery disease	0.000348	0.00121	CcSEcCtD
Mivacurium—CHRM2—Signaling Pathways—APOC3—coronary artery disease	2.25e-05	0.000162	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LDLR—coronary artery disease	2.23e-05	0.000161	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AGT—coronary artery disease	2.22e-05	0.00016	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PPP2CA—coronary artery disease	2.21e-05	0.00016	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GSTM1—coronary artery disease	2.21e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL2—coronary artery disease	2.2e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL3—coronary artery disease	2.2e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AGT—coronary artery disease	2.2e-05	0.000159	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PPP2CA—coronary artery disease	2.19e-05	0.000158	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PLCB1—coronary artery disease	2.19e-05	0.000158	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL3—coronary artery disease	2.18e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL2—coronary artery disease	2.18e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2R—coronary artery disease	2.18e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SDC1—coronary artery disease	2.18e-05	0.000157	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PRKCD—coronary artery disease	2.17e-05	0.000157	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—LPL—coronary artery disease	2.17e-05	0.000156	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SDC1—coronary artery disease	2.16e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2R—coronary artery disease	2.16e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PRKCD—coronary artery disease	2.15e-05	0.000155	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGB—coronary artery disease	2.13e-05	0.000154	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—HTR2A—coronary artery disease	2.13e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—C3—coronary artery disease	2.12e-05	0.000153	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ABCA1—coronary artery disease	2.12e-05	0.000153	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—GPX1—coronary artery disease	2.12e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGB—coronary artery disease	2.11e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDNRB—coronary artery disease	2.11e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—HTR2A—coronary artery disease	2.11e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—C3—coronary artery disease	2.1e-05	0.000152	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDNRB—coronary artery disease	2.09e-05	0.000151	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—THBS1—coronary artery disease	2.08e-05	0.00015	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—CD36—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—THBS1—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PSMA6—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PSMB5—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GGT1—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GOT1—coronary artery disease	2.06e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—F2—coronary artery disease	2.05e-05	0.000148	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PSMB5—coronary artery disease	2.04e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PSMA6—coronary artery disease	2.04e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—F2—coronary artery disease	2.03e-05	0.000147	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPP2CA—coronary artery disease	2.03e-05	0.000147	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AGT—coronary artery disease	2.02e-05	0.000145	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AGT—coronary artery disease	2e-05	0.000144	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDNRA—coronary artery disease	1.99e-05	0.000144	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CYBA—coronary artery disease	1.98e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB1—coronary artery disease	1.98e-05	0.000143	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—DUSP6—coronary artery disease	1.98e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDNRA—coronary artery disease	1.97e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB1—coronary artery disease	1.96e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CYBA—coronary artery disease	1.96e-05	0.000142	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—DUSP6—coronary artery disease	1.96e-05	0.000141	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—MTHFR—coronary artery disease	1.95e-05	0.000141	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLAT—coronary artery disease	1.94e-05	0.00014	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLAT—coronary artery disease	1.92e-05	0.000139	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL12—coronary artery disease	1.87e-05	0.000135	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—BDKRB2—coronary artery disease	1.87e-05	0.000135	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—POMC—coronary artery disease	1.87e-05	0.000135	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—F2—coronary artery disease	1.87e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6ST—coronary artery disease	1.86e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—BDKRB2—coronary artery disease	1.86e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL12—coronary artery disease	1.86e-05	0.000134	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AGT—coronary artery disease	1.85e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—POMC—coronary artery disease	1.85e-05	0.000134	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTP1—coronary artery disease	1.85e-05	0.000133	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—F2—coronary artery disease	1.85e-05	0.000133	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6ST—coronary artery disease	1.84e-05	0.000133	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—JUNB—coronary artery disease	1.84e-05	0.000133	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLCB1—coronary artery disease	1.83e-05	0.000132	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARGC1A—coronary artery disease	1.83e-05	0.000132	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—HMOX1—coronary artery disease	1.82e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—JUNB—coronary artery disease	1.82e-05	0.000131	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOE—coronary artery disease	1.82e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLCB1—coronary artery disease	1.81e-05	0.000131	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CAT—coronary artery disease	1.8e-05	0.00013	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—APOA1—coronary artery disease	1.8e-05	0.000129	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR7—coronary artery disease	1.79e-05	0.000129	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR7—coronary artery disease	1.78e-05	0.000128	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOB—coronary artery disease	1.75e-05	0.000126	CbGpPWpGaD
Mivacurium—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.72e-05	0.000124	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGAV—coronary artery disease	1.71e-05	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KNG1—coronary artery disease	1.7e-05	0.000123	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—POMC—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CREB1—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GSTM1—coronary artery disease	1.7e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGTR1—coronary artery disease	1.69e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGAV—coronary artery disease	1.69e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KNG1—coronary artery disease	1.69e-05	0.000122	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—POMC—coronary artery disease	1.68e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CREB1—coronary artery disease	1.68e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGTR1—coronary artery disease	1.68e-05	0.000121	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—LPL—coronary artery disease	1.67e-05	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CCL2—coronary artery disease	1.66e-05	0.00012	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6R—coronary artery disease	1.66e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL10—coronary artery disease	1.66e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PLG—coronary artery disease	1.65e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CCL2—coronary artery disease	1.65e-05	0.000119	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6R—coronary artery disease	1.64e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL10—coronary artery disease	1.64e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PLG—coronary artery disease	1.64e-05	0.000118	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—GPX1—coronary artery disease	1.63e-05	0.000117	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ADRB2—coronary artery disease	1.61e-05	0.000116	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ADRB2—coronary artery disease	1.59e-05	0.000115	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCE—coronary artery disease	1.59e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—JAK2—coronary artery disease	1.59e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—CD36—coronary artery disease	1.58e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS1—coronary artery disease	1.58e-05	0.000114	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PPARG—coronary artery disease	1.58e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—S100B—coronary artery disease	1.58e-05	0.000114	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCE—coronary artery disease	1.57e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—JAK2—coronary artery disease	1.57e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS1—coronary artery disease	1.57e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPP2CA—coronary artery disease	1.56e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—S100B—coronary artery disease	1.56e-05	0.000113	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SOCS3—coronary artery disease	1.56e-05	0.000113	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—POMC—coronary artery disease	1.56e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SOCS3—coronary artery disease	1.55e-05	0.000112	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KITLG—coronary artery disease	1.55e-05	0.000111	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFBR2—coronary artery disease	1.55e-05	0.000111	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KITLG—coronary artery disease	1.53e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFBR2—coronary artery disease	1.53e-05	0.00011	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—STAT5A—coronary artery disease	1.51e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP3—coronary artery disease	1.51e-05	0.000109	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—MTHFR—coronary artery disease	1.5e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP3—coronary artery disease	1.5e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—STAT5A—coronary artery disease	1.5e-05	0.000108	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOB—coronary artery disease	1.46e-05	0.000105	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—CXCL8—coronary artery disease	1.45e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOB—coronary artery disease	1.45e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—JAK2—coronary artery disease	1.44e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—EDN1—coronary artery disease	1.44e-05	0.000104	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—CXCL8—coronary artery disease	1.43e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—JAK2—coronary artery disease	1.43e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AGT—coronary artery disease	1.43e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL5—coronary artery disease	1.43e-05	0.000103	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—ALB—coronary artery disease	1.42e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—EDN1—coronary artery disease	1.42e-05	0.000103	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL5—coronary artery disease	1.41e-05	0.000102	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGF1—coronary artery disease	1.4e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CSF2—coronary artery disease	1.4e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOE—coronary artery disease	1.4e-05	0.000101	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LPL—coronary artery disease	1.39e-05	0.0001	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGF1—coronary artery disease	1.39e-05	0.0001	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CSF2—coronary artery disease	1.39e-05	0.0001	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—RPS6KB1—coronary artery disease	1.38e-05	9.95e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MEF2C—coronary artery disease	1.38e-05	9.95e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—APOA1—coronary artery disease	1.38e-05	9.95e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LPL—coronary artery disease	1.38e-05	9.95e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MEF2C—coronary artery disease	1.37e-05	9.86e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—RPS6KB1—coronary artery disease	1.37e-05	9.86e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—NOS3—coronary artery disease	1.36e-05	9.81e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ITGB3—coronary artery disease	1.35e-05	9.7e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ITGB3—coronary artery disease	1.33e-05	9.61e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—CXCL8—coronary artery disease	1.31e-05	9.47e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PPP2CA—coronary artery disease	1.31e-05	9.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—CXCL8—coronary artery disease	1.3e-05	9.38e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PPP2CA—coronary artery disease	1.3e-05	9.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PRKCD—coronary artery disease	1.28e-05	9.25e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PRKCD—coronary artery disease	1.27e-05	9.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HTR2A—coronary artery disease	1.26e-05	9.06e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—C3—coronary artery disease	1.26e-05	9.04e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PTGS2—coronary artery disease	1.25e-05	8.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HTR2A—coronary artery disease	1.24e-05	8.97e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—C3—coronary artery disease	1.24e-05	8.96e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PPARG—coronary artery disease	1.22e-05	8.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—POMC—coronary artery disease	1.2e-05	8.65e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—HIF1A—coronary artery disease	1.2e-05	8.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AGT—coronary artery disease	1.19e-05	8.59e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—HIF1A—coronary artery disease	1.19e-05	8.54e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AGT—coronary artery disease	1.18e-05	8.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—LEP—coronary artery disease	1.17e-05	8.42e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOE—coronary artery disease	1.17e-05	8.42e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—LEP—coronary artery disease	1.16e-05	8.34e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOE—coronary artery disease	1.16e-05	8.34e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—APOA1—coronary artery disease	1.16e-05	8.32e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KDR—coronary artery disease	1.14e-05	8.25e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—APOA1—coronary artery disease	1.14e-05	8.24e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK14—coronary artery disease	1.14e-05	8.19e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KDR—coronary artery disease	1.13e-05	8.17e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK14—coronary artery disease	1.13e-05	8.11e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—ESR1—coronary artery disease	1.12e-05	8.04e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—ESR1—coronary artery disease	1.1e-05	7.96e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—F2—coronary artery disease	1.1e-05	7.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FN1—coronary artery disease	1.1e-05	7.94e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6ST—coronary artery disease	1.1e-05	7.91e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—ALB—coronary artery disease	1.09e-05	7.89e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FN1—coronary artery disease	1.09e-05	7.86e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—F2—coronary artery disease	1.09e-05	7.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NFKBIA—coronary artery disease	1.09e-05	7.85e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6ST—coronary artery disease	1.09e-05	7.83e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NFKBIA—coronary artery disease	1.08e-05	7.77e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—KIT—coronary artery disease	1.05e-05	7.6e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—NOS3—coronary artery disease	1.05e-05	7.54e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—KIT—coronary artery disease	1.04e-05	7.52e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—GSK3B—coronary artery disease	1.01e-05	7.29e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—POMC—coronary artery disease	1e-05	7.23e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CREB1—coronary artery disease	1e-05	7.23e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—GSK3B—coronary artery disease	1e-05	7.22e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—POMC—coronary artery disease	9.94e-06	7.16e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CREB1—coronary artery disease	9.94e-06	7.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCL2—coronary artery disease	9.82e-06	7.08e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6R—coronary artery disease	9.79e-06	7.06e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCL2—coronary artery disease	9.73e-06	7.01e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6R—coronary artery disease	9.7e-06	6.99e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IGF1—coronary artery disease	9.65e-06	6.96e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—MAPK1—coronary artery disease	9.61e-06	6.92e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PTGS2—coronary artery disease	9.57e-06	6.9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IGF1—coronary artery disease	9.56e-06	6.89e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—MAPK1—coronary artery disease	9.52e-06	6.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—PIK3CA—coronary artery disease	9.18e-06	6.62e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—SERPINE1—coronary artery disease	9.17e-06	6.61e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—PIK3CA—coronary artery disease	9.09e-06	6.55e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—SERPINE1—coronary artery disease	9.08e-06	6.54e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—FGF2—coronary artery disease	8.88e-06	6.4e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—FGF2—coronary artery disease	8.79e-06	6.33e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—NOS3—coronary artery disease	8.75e-06	6.31e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—NOS3—coronary artery disease	8.67e-06	6.25e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—JAK2—coronary artery disease	8.51e-06	6.13e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—JAK2—coronary artery disease	8.42e-06	6.07e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—PIK3CA—coronary artery disease	8.34e-06	6.01e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—PIK3CA—coronary artery disease	8.26e-06	5.95e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CXCL8—coronary artery disease	7.76e-06	5.59e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CXCL8—coronary artery disease	7.69e-06	5.54e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—PIK3CA—coronary artery disease	7.66e-06	5.52e-05	CbGpPWpGaD
Mivacurium—CHRM3—GPCR downstream signaling—AKT1—coronary artery disease	7.5e-06	5.4e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CASP3—coronary artery disease	7.43e-06	5.36e-05	CbGpPWpGaD
Mivacurium—CHRM2—GPCR downstream signaling—AKT1—coronary artery disease	7.43e-06	5.35e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—IL6—coronary artery disease	7.38e-06	5.32e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CASP3—coronary artery disease	7.36e-06	5.3e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—IL6—coronary artery disease	7.31e-06	5.27e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—CCND1—coronary artery disease	7.23e-06	5.21e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—CCND1—coronary artery disease	7.16e-06	5.16e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MMP9—coronary artery disease	7.02e-06	5.06e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MMP9—coronary artery disease	6.95e-06	5.01e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling by GPCR—AKT1—coronary artery disease	6.81e-06	4.91e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling by GPCR—AKT1—coronary artery disease	6.75e-06	4.86e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—VEGFA—coronary artery disease	6.31e-06	4.54e-05	CbGpPWpGaD
Mivacurium—BCHE—Metabolism—AKT1—coronary artery disease	6.26e-06	4.51e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—VEGFA—coronary artery disease	6.25e-06	4.5e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—PIK3CA—coronary artery disease	5.89e-06	4.24e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—TGFB1—coronary artery disease	5.79e-06	4.17e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—TGFB1—coronary artery disease	5.73e-06	4.13e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—MAPK1—coronary artery disease	5.68e-06	4.09e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—MAPK1—coronary artery disease	5.62e-06	4.05e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—PIK3CA—coronary artery disease	4.93e-06	3.55e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—PIK3CA—coronary artery disease	4.88e-06	3.51e-05	CbGpPWpGaD
Mivacurium—CHRM3—Metabolism—AKT1—coronary artery disease	4.81e-06	3.47e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—IL6—coronary artery disease	4.36e-06	3.14e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—IL6—coronary artery disease	4.32e-06	3.11e-05	CbGpPWpGaD
Mivacurium—CHRM3—Signaling Pathways—AKT1—coronary artery disease	4.02e-06	2.9e-05	CbGpPWpGaD
Mivacurium—CHRM2—Signaling Pathways—AKT1—coronary artery disease	3.98e-06	2.87e-05	CbGpPWpGaD
